Our data hinted that MAFG-AS1 regulated HCC cell growth and migration through the miR-3196/STRN4 axis, exposing a potential neo-biomarker for diagnosis or treatment for liver cancer patients. The gene discussed is MAFG; the disease is hepatocellular carcinoma.